Skip to content
Danforth Advisors
Magnifying Glass Icon
Primary Menu Toggle Icon
  • Capabilities
    • Run the Business
      • Operational Finance and Accounting
      • Financing Strategy and Execution
      • IPO Preparation and Execution
      • Accounting and Reporting Advisory
      • Strategic Communications
      • Human Resources
      • Risk Management
    • Develop Assets
      • Medical Advisory
      • Regulatory
      • Clinical Development Operations
      • Clinical Business Operations
    • Launch Products
      • Market Access & Value
      • Market Research
      • Commercial Readiness
  • How We Work
    • Client Success
  • News/Resources
  • Our Team
    • Join Us
  • Contact Us

Resources

  • Biotech Risk Management: How to Protect Your Life Sciences Organization

    Insights on the importance of risk assessment and mitigation strategies

  • Biotech CEOs Should Focus on Optionality to Land the Best Opportunity

    The importance of readiness, strategic differentiation, and de-risking the science to attract investors

  • Danforth Advisors Acquires VPMR

    We now provide global market research to inform strategy for life science companies

Corporate News
Danforth Advisors Establishes Market Access Division

Helping life science companies simplify market access, navigate payer complexity and guide reimbursement strategy

Insights
How to Improve Collaboration Around Clinical Trial Financial Accruals

Discover a smarter CRO selection strategy that aligns with your clinical trial goals, resources, and long-term success.

Insights
Clinical Trial Financial Accruals: What Every Clinical Professional Needs to Know

Discover a smarter CRO selection strategy that aligns with your clinical trial goals, resources, and long-term success.

Insights
CRO Contract Best Practices: Why life science companies should treat CRO contracting as a strategic asset, not just a legal formality. 

Discover a smarter CRO selection strategy that aligns with your clinical trial goals, resources, and long-term success.

Insights
BIOSECURE Act Compliance: 5 Key Steps Biotech Leaders Must Take Now

Preparing for the potential impact of the BIOSECURE Act

Insights
The Fibonacci Approach to Life Sciences Commercialization Strategy

Simplifying commercial readiness in biopharma

Insights
The Connection Point: Transforming Pharmaceutical Data into Strategic Intelligence

Pharma companies that master pharmaceutical data integration will lead in an increasingly complex market

Insights
Simplify for Success: A Biotech Commercialization Strategy That Works

A strong commercialization strategy is crucial for fostering innovation, reducing time-to-market, and enhancing accessibility

Insights
Performance Management in Biotech: 3 Ways to Support Your People

Building people-first performance management strategies in biotech

Insights
Biotech Goal Setting: Why It’s a Mistake to Wait for the Board Meeting

Start biotech goal setting before the board meets. Learn how a rolling approach boosts momentum, alignment, and execution from Danforth Advisors.

Insights
Immigration Policy in Biotech Companies: 3 Things Leaders Need to Know 

The time to define expectations and protect your culture is now.

Insights
3 Essential Practices for Managing Civil Discourse in the Workplace: Are You Prepared?

The time to define expectations and protect your culture is now.

Case Studies
CRO Selection Strategy: Reframing the Question for Clinical Trial Success

Discover a smarter CRO selection strategy that aligns with your clinical trial goals, resources, and long-term success.

Insights
Mastering Cash Flow Management for Life Science Startups: Strategies for Financial Risk Mitigation

Key financial strategies to ensure sustainable growth

Insights
Operational Resilience for Biotech Startups: Best Practices for Early-Stage Companies

Follow these principles to establish a resilient foundation

Insights
Goal Setting Best Practices for Biotech Companies: Powerful Strategies for High Performance

Applying the SMART goal framework

Corporate News
Ganda Business Solutions and Danforth Advisors Align to Support Swiss Biotechs

Providing strategic and operational support to help Swiss biotechs scale and expand to the US

Insights
Biotech IPO Strategy: What to Do Now

Take these steps to position your company for all possible financing opportunities

  • Capabilities
  • How We Work
  • News/Resources
  • Danforth Inside
  • Our Team
  • Join Us
  • Contact Us
  • Sitemap
  • Terms and Conditions
  • Privacy Policy
  • Subscribe to our quarterly newsletter for insights, news, and events.

©2025 Danforth Advisors. All Rights Reserved.

Knowledge. Discipline. Perspective.